How Priority Health’s Pharmacy & Therapeutics Committee Approves Drugs—and What It Means for Patients
May 7, 2026 — For millions of Americans covered under Priority Health’s insurance plans—including those tied to Corewell Health (formerly Beaumont Health)—the approval of prescription drugs isn’t just a bureaucratic process. It’s a critical determinant of access to life-saving and life-improving medications. As the parent organization of Corewell Health, Priority Health’s formulary decisions carry weight for patients, providers, and pharmaceutical companies alike. But how exactly does the system function? And what happens when a drug’s approval hinges on clinical evidence, cost, and patient need?
In an era where drug pricing, formulary exclusions, and prior authorization policies dominate healthcare debates, understanding the Pharmacy & Therapeutics (P&T) Committee process is more key than ever. Below, we break down how Priority Health evaluates and approves drugs, the criteria that matter, and what patients and providers should know if their preferred medication isn’t covered.
— ###
The Role of the P&T Committee: Gatekeepers of the Formulary
At the heart of Priority Health’s drug approval process is the Pharmacy & Therapeutics (P&T) Committee, a multidisciplinary body tasked with ensuring that the medications covered under the insurer’s formulary are safe, effective, and cost-efficient. The committee meets six times a year and includes:
From Instagram — related to Corewell Health, Medicare Advantage
Actively practicing physicians (specialists in areas like oncology, cardiology, and infectious disease)
Pharmacists with expertise in clinical pharmacy and drug utilization
Representatives from Priority Health’s Pharmacy and Medical departments
The P&T Committee’s decisions shape the Approved Drug List (formulary), which varies by plan type—whether it’s employer-sponsored coverage, Medicare, Medicaid, or Corewell Health-affiliated programs. Importantly, even if a drug is listed as “approved” for a given plan, individual employers or providers may still exclude it. Patients are advised to check their specific coverage documents or contact Priority Health’s Customer Service (800.942.0954) for clarity.
Why does this matter? Formulary decisions directly impact patient access. A drug approved for one Priority Health plan (e.g., Medicare Advantage) may not be covered under another (e.g., an employer group plan), creating potential gaps in care. For patients with chronic conditions—such as diabetes, cancer, or autoimmune disorders—these distinctions can be life-altering.
— ###
How Drugs Get Approved: The 5 Key Criteria
Not all drugs make it onto Priority Health’s formulary. The P&T Committee evaluates each medication against five core criteria, as outlined in the insurer’s official guidelines. Here’s what they look for:
1. Scientific Evidence & Clinical Standards Does the drug have peer-reviewed, published data demonstrating efficacy and safety? The committee prioritizes medications with FDA approval and well-established clinical guidelines from organizations like the National Guideline Clearinghouse or American College of Physicians.
2. Therapeutic Advantage Does the drug offer a meaningful improvement over existing treatments? Factors include:
Superior efficacy in reducing symptoms or improving outcomes
Fewer side effects or better tolerability
Unique mechanisms of action (e.g., a new class of antidepressants for treatment-resistant depression)
Example: A new FDA-approved cancer immunotherapy might be fast-tracked if clinical trials show it extends survival by 12+ months compared to standard care.
3. Pharmacoeconomics: Cost vs. Value Even the most innovative drugs must justify their price tag. The P&T Committee reviews:
Therapeutic value per dollar (e.g., cost per quality-adjusted life year, or QALY)
Generic alternatives (if available)
Potential budget impact on Priority Health’s overall formulary costs
Note: Medicaid members may also qualify for non-prescription items (e.g., glucose monitors, first-aid supplies) under Priority Health’s expanded benefits. Details here.
Medication Approval Explained Drug Utilization Review
4. Drug Utilization Review (DUR) Safeguards The committee oversees quality assurance programs to prevent misuse, including:
Prospective reviews (before a prescription is filled)
Retrospective audits (after dispensing)
Concurrent monitoring (real-time alerts for high-risk medications)
Red flags include therapeutic duplication (taking two blood pressure meds with overlapping effects), drug-drug interactions, or off-label use without clinical justification.
Care management teams assisting members with chronic conditions
Example: If a new CDC-recommended vaccine is approved but providers report supply chain delays, the committee may adjust formulary terms temporarily.
Key Takeaway: The approval process is not just about science—it’s about balancing safety, efficacy, and affordability. Drugs that fail to meet these criteria may be excluded or subject to prior authorization (requiring pre-approval from the insurer).
— ###
What Happens If Your Drug Isn’t Covered?
If a medication you or a loved one needs isn’t on Priority Health’s formulary, you’re not without options. Here’s what to do:
Medication Approval Explained
Check for Exceptions
Some drugs may be covered under non-formulary benefits or through step therapy (trying a preferred drug first). Contact Priority Health’s Pharmacy Services to explore alternatives.
Request a Prior Authorization
If your doctor believes a non-formulary drug is medically necessary, they can submit a prior authorization request. The P&T Committee reviews these on a case-by-case basis.
Appeal the Decision
If denied, you can appeal by providing additional clinical evidence (e.g., lab results, specialist letters). Priority Health’s Drug Utilization Review process outlines the steps.
Explore Patient Assistance Programs
Many pharmaceutical companies offer discounts or free medications for low-income patients. Ask your pharmacist or provider about programs like:
Pro Tip: If you’re a Medicaid recipient, Priority Health may cover some over-the-counter items (e.g., insulin supplies, allergy meds). Call 888.975.8102 to confirm eligibility.
— ###
FAQ: Common Questions About Priority Health’s Formulary
Q: How often does Priority Health update its formulary?
The P&T Committee meets six times a year, and updates are typically reflected in the formulary quarterly. Major changes (e.g., new FDA approvals) may be implemented sooner.
Q: Can my employer add a drug to their plan even if it’s not on Priority Health’s formulary?
Yes. Even as Priority Health establishes a base formulary, individual employers or Medicare Advantage plans can customize coverage. Always review your plan documents or ask your HR representative.
Q: What’s the difference between a formulary drug and a non-formulary drug?
Formulary drugs are preferred and usually have lower out-of-pocket costs. Non-formulary drugs may require prior authorization, step therapy, or higher copays. Some non-formulary drugs are never covered unless medically necessary.
Q: How does Priority Health handle experimental or off-label drugs?
Experimental drugs (not FDA-approved) are rarely covered unless part of a clinical trial. Off-label use (prescribing a drug for a purpose other than its FDA approval) is evaluated on a case-by-case basis, typically requiring detailed clinical justification.
— ###
The Bigger Picture: Formularies in the Age of High-Cost Drugs
Priority Health’s approach to drug approval reflects a broader trend in U.S. Healthcare: insurers are under pressure to control costs while maintaining access to innovative therapies. With biologics and gene therapies costing $100,000+ per patient, formulary decisions have never been more scrutinized.
Medication Approval Explained Formularies
Key trends to watch:
Value-based contracting: More insurers (including Priority Health) are negotiating performance-based pricing with drugmakers (e.g., paying only if a medication meets efficacy targets).
Patient advocacy influence: Groups like the Global Genes Alliance are pushing for faster approval of orphan drugs (for rare diseases).
AI in formulary management: Some insurers use predictive analytics to forecast drug utilization and adjust formularies proactively.
For patients, the message is clear: Stay informed about your coverage. If you’re prescribed a medication not on Priority Health’s formulary, ask your doctor about alternatives, appeals, or assistance programs. And if you’re a provider, engage with the P&T Committee early—their decisions shape the care you can deliver.
— ###
Final Takeaways: What You Need to Know
To summarize:
The P&T Committee is the final authority on Priority Health’s drug formulary, meeting six times yearly to evaluate safety, efficacy, and cost.
Approval depends on clinical evidence, therapeutic advantage, and economic value—not just FDA status.
If your drug isn’t covered, exceptions, prior authorization, and appeals may help. Patient assistance programs can also reduce costs.
Formularies are evolving: value-based contracts and AI are reshaping how insurers and drugmakers negotiate access.
As healthcare costs continue to rise, understanding how your insurer approves medications is not just a technicality—it’s a tool for better health outcomes. Whether you’re a patient, provider, or employer, knowing the process ensures you can advocate effectively for the treatments you need.
